Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.
NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial NCT06593600 is recruiting (started Nov 2024, primary completion Mar 2026). No public readout or results available as of Apr 2026. All sources confirm ongoing status without efficacy data or interpretation.
Found Apr 6, 2026, 2:59 PMReviewed Apr 6, 2026, 3:00 PM
NO_DECISIONDismissed90% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial recruiting with primary completion in Mar 2026. No public readout or efficacy results available. Phase 1 data positive on BP but not this exact Phase 2 POTS trial.
Found Apr 6, 2026, 2:10 PMReviewed Apr 6, 2026, 2:25 PM
NO_DECISIONDismissed90% confidencemanual-chat-review
Will the results be positive?
ClinicalTrials.gov still lists this study as recruiting with no posted results, so there is not yet a clear public positive or negative trial readout.
Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:33 PM
NO_DECISIONDismissed86% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific public readout was found. The sponsor publicly described REGN7544 in POTS as a Phase 2 study that was initiated, and the trial registry still showed Recruiting with estimated primary completion on 2026-03-20 and last verification in Feb 2026. That is insufficient to call results positive or negative.
Found Apr 3, 2026, 4:30 PMReviewed Apr 3, 2026, 4:46 PM
NO_DECISIONDismissed97% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific public efficacy readout was found. Cited sources indicate REGN7544 POTS Phase 2 was only initiated in February 2025, and a current trial listing still shows open enrollment with no publications/results available. That is insufficient to call this trial positive or negative.
Found Apr 1, 2026, 7:54 PMReviewed Apr 1, 2026, 7:55 PM